|
INVS expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.85890003390199E-09 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.43340023079008E-10 |
| Normal-vs-Stage2 |
4.217800E-03 |
| Normal-vs-Stage3 |
2.06540000002864E-06 |
| Normal-vs-Stage4 |
1.900250E-03 |
| Stage1-vs-Stage2 |
1.701010E-01 |
| Stage1-vs-Stage3 |
9.399000E-01 |
| Stage1-vs-Stage4 |
8.145600E-01 |
| Stage2-vs-Stage3 |
3.256000E-01 |
| Stage2-vs-Stage4 |
5.895000E-01 |
| Stage3-vs-Stage4 |
8.731400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.18599996279789E-09 |
| Normal-vs-AfricanAmerican |
5.10150000021525E-07 |
| Normal-vs-Asian |
5.436000E-03 |
| Caucasian-vs-AfricanAmerican |
8.494200E-01 |
| Caucasian-vs-Asian |
9.698200E-01 |
| AfricanAmerican-vs-Asian |
9.160600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.6503465261053E-12 |
| Normal-vs-Female |
2.182100E-03 |
| Male-vs-Female |
3.364000E-04 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
8.71919999534398E-08 |
| Normal-vs-Extreme_Weight |
1.63513647066793E-12 |
| Normal-vs-Obese |
3.243600E-04 |
| Normal-vs-Extreme_Obese |
3.301800E-03 |
| Normal_Weight-vs-Extreme_Weight |
9.538400E-02 |
| Normal_Weight-vs-Obese |
1.241770E-01 |
| Normal_Weight-vs-Extreme_Obese |
4.780400E-01 |
| Extreme_Weight-vs-Obese |
9.412100E-04 |
| Extreme_Weight-vs-Extreme_Obese |
6.287600E-02 |
| Obese-vs-Extreme_Obese |
7.836800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.120300E-02 |
| Normal-vs-Age(41-60Yrs) |
4.93529999978648E-07 |
| Normal-vs-Age(61-80Yrs) |
2.70069966390452E-10 |
| Normal-vs-Age(81-100Yrs) |
4.15679999998808E-06 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.551400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.731800E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.008170E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.534220E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.232000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.991800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.09209974397118E-10 |
| Normal-VS-Type2 PRCC |
1.42079999987388E-07 |
| Normal-VS-KIRP CIMP |
5.750800E-01 |
| Normal-VS-Unclassified PRCC |
1.117520E-03 |
| Type1 PRCC-VS-Type2 PRCC |
9.979600E-01 |
| Type1 PRCC-VS-KIRP CIMP |
1.446760E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
2.095600E-01 |
| Type2 PRCC-VS-KIRP CIMP |
1.509800E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
2.270800E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
2.218200E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
8.72850003386105E-09 |
| Normal-vs-N1 |
7.755400E-03 |
| Normal-vs-N2 |
3.550400E-02 |
| N0-vs-N1 |
1.168960E-01 |
| N0-vs-N2 |
7.203800E-01 |
| N1-vs-N2 |
6.773000E-01 |
|
|
